Guangyuan Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Guangyuan Zhang has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Nan Lu
Pathogen Biology and Immunology Laboratory, Lab Teaching & Management Center, School of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China
6 shared publications Guangchao Zang
Pathogen Biology and Immunology Laboratory, Lab Teaching & Management Center, School of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China
4 shared publicationsSiyuan Wang
Department of Thyroid, Breast and Vascular Surgery, Xi Jing Hospital, Air Force Medical University, Xi'an, 710032, China
3 shared publicationsXia Huang
Pathogen Biology and Immunology Laboratory, Lab Teaching & Management Center, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, China
3 shared publications- Chaoliang Zhang
Pathogen Biology and Immunology Laboratory and Laboratory of Tissue and Cell Biology, Experimental Teaching and Management Center, Chongqing Medical University, Chongqing 401331, China
2 shared publications - Guangchao Zang
Biomedical Innovation and Entrepreneurship Practice Base, Lab Teaching & Management Center, Chongqing Medical University, Chongqing, China
2 shared publications
Latest Publications
- Open Access
- 1 May 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (3) , 101845
Salt-inducible kinase 1 is a key gene in suppressing EVD68-induced asthma by modulating antiviral immunity
Asthma is a complex inflammatory disease of the airways, affecting over 300 million individuals globally. Infection with enterovirus D68 (EV-D68) has been identified as a risk factor for asthma. However, the biological mechanisms of EV-D68-related asthma remain unclear. In this study, using machine learning techniques, we identified salt-inducible kinase 1 (SIK1), which plays a crucial role in associating with the asthma phenotype and EV-D68 infection. Concretely, a negative correlation between SIK1 expression and asthma risk has been revealed through Mendelian randomization. Immune infiltration analyses showed that SIK1 was negatively correlated with mast cell activity and positively correlated with T cell responses. Using weighted gene co-expression network analysis, we demonstrated SIK1's role in antiviral immune responses in asthma. Further in vitro and in vivo experiments confirmed that SIK1 was up-regulated in virus infection, and it exerted antiviral effects in various viral infections. Finally, in the asthma exacerbation model of HDM combined with EV-D68 infection, SIK1 activation effectively mitigated EV-D68-induced asthma exacerbation in mice. Taken together, our findings suggest that SIK1 serves as a protective factor in EV-D68-induced asthma by modulating antiviral immune responses, which provide new insights into potential treatments for EV-D68-induced asthma attacks.
- 1 May 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (3) , 101845
Open AccessSalt-inducible kinase 1 is a key gene in suppressing EVD68-induced asthma by modulating antiviral immunity
Asthma is a complex inflammatory disease of the airways, affecting over 300 million individuals globally. Infection with enterovirus D68 (EV-D68) has been identified as a risk factor for asthma. However, the biological mechanisms of EV-D68-related asthma remain unclear. In this study, using machine learning techniques, we identified salt-inducible kinase 1 (SIK1), which plays a crucial role in associating with the asthma phenotype and EV-D68 infection. Concretely, a negative correlation between SIK1 expression and asthma risk has been revealed through Mendelian randomization. Immune infiltration analyses showed that SIK1 was negatively correlated with mast cell activity and positively correlated with T cell responses. Using weighted gene co-expression network analysis, we demonstrated SIK1's role in antiviral immune responses in asthma. Further in vitro and in vivo experiments confirmed that SIK1 was up-regulated in virus infection, and it exerted antiviral effects in various viral infections. Finally, in the asthma exacerbation model of HDM combined with EV-D68 infection, SIK1 activation effectively mitigated EV-D68-induced asthma exacerbation in mice. Taken together, our findings suggest that SIK1 serves as a protective factor in EV-D68-induced asthma by modulating antiviral immune responses, which provide new insights into potential treatments for EV-D68-induced asthma attacks.
- Open Access
- 1 August 2025
- Published by KEAI Publishing in Virologica Sinica
- Vol. 40 (4) , 658-668
ARRDC3 promotes lysosome-mediated YAP degradation to inhibit enterovirus replication
Enterovirus D68 (EV-D68) and enterovirus A71 (EV-A71) are two major types of enteroviruses that pose emerging challenges to public health and have the potential to cause outbreaks, yet their pathogenic mechanisms remain largely unexplored. Arrestin domain containing 3 (ARRDC3) is a vital regulator of glucose metabolism, cancer development, and inflammation. Whether ARRDC3 contributes to innate antiviral immunity is undefined. Here, we found that enterovirus infection induces ARRDC3 expression at both the mRNA and protein levels, thereby inhibiting enterovirus replication. Moreover, we demonstrate that the expression of Yes-associated protein (YAP), a key effector of the Hippo pathway, is severely downregulated by ARRDC3 via lysosomal pathway. YAP facilitates enterovirus replication by suppressing the interferon pathway during the later stage of enterovirus infection, independent of its transcriptional activity. Finally, the ARRDC3-YAP pathway exhibits a broad-spectrum antiviral effect in various viral infections, including those caused by human parainfluenza virus type 3 (HPIV3) and vesicular stomatitis virus (VSV). Collectively, our results identify the critical role of ARRDC3 and its negative regulatory effect on YAP in the innate antiviral response, suggesting a novel therapeutic strategy against virus infection.
- 1 August 2025
- Published by KEAI Publishing in Virologica Sinica
- Vol. 40 (4) , 658-668
Open AccessARRDC3 promotes lysosome-mediated YAP degradation to inhibit enterovirus replication
Enterovirus D68 (EV-D68) and enterovirus A71 (EV-A71) are two major types of enteroviruses that pose emerging challenges to public health and have the potential to cause outbreaks, yet their pathogenic mechanisms remain largely unexplored. Arrestin domain containing 3 (ARRDC3) is a vital regulator of glucose metabolism, cancer development, and inflammation. Whether ARRDC3 contributes to innate antiviral immunity is undefined. Here, we found that enterovirus infection induces ARRDC3 expression at both the mRNA and protein levels, thereby inhibiting enterovirus replication. Moreover, we demonstrate that the expression of Yes-associated protein (YAP), a key effector of the Hippo pathway, is severely downregulated by ARRDC3 via lysosomal pathway. YAP facilitates enterovirus replication by suppressing the interferon pathway during the later stage of enterovirus infection, independent of its transcriptional activity. Finally, the ARRDC3-YAP pathway exhibits a broad-spectrum antiviral effect in various viral infections, including those caused by human parainfluenza virus type 3 (HPIV3) and vesicular stomatitis virus (VSV). Collectively, our results identify the critical role of ARRDC3 and its negative regulatory effect on YAP in the innate antiviral response, suggesting a novel therapeutic strategy against virus infection.
- Open Access
NAD+ Suppresses EV-D68 Infection by Enhancing Anti-Viral Effect of SIRT1
Enterovirus 68 (EV-D68) is a non-enveloped virus with a positive-sense single-stranded RNA genome that causes respiratory diseases and acute flaccid myelitis, posing significant threats to human health. However, an effective vaccine remains undeveloped. SIRT1, a nicotinamide adenine dinucleotide (NAD+)-dependent enzyme, plays a key role in cellular metabolism, but its interaction with NAD+ during viral infections is not well understood. In this study, through a metabolomics analysis, we demonstrate that EV-D68 infection influences cellular metabolism. Additionally, we show that NAD+ inhibits EV-D68 infection both in vivo and in vitro. EV-D68 reduces cellular NAD+ levels by regulating the expression of enzymes involved in NAD+ consumption and synthesis. Moreover, the infection increases the expression of sirtuin 1 (SIRT1), which inhibits EV-D68 replication in turn. Mechanistically, SIRT1 suppresses EV-D68 5′UTR-mediated translation, and the antiviral effect of SIRT1 on EV-D68 replication is enhanced by NAD+. Collectively, our findings highlight the critical role of NAD+ metabolism in EV-D68 infection and reveal the antiviral potential of SIRT1, providing valuable insights for the development of antiviral strategies.
Open AccessNAD+ Suppresses EV-D68 Infection by Enhancing Anti-Viral Effect of SIRT1
Enterovirus 68 (EV-D68) is a non-enveloped virus with a positive-sense single-stranded RNA genome that causes respiratory diseases and acute flaccid myelitis, posing significant threats to human health. However, an effective vaccine remains undeveloped. SIRT1, a nicotinamide adenine dinucleotide (NAD+)-dependent enzyme, plays a key role in cellular metabolism, but its interaction with NAD+ during viral infections is not well understood. In this study, through a metabolomics analysis, we demonstrate that EV-D68 infection influences cellular metabolism. Additionally, we show that NAD+ inhibits EV-D68 infection both in vivo and in vitro. EV-D68 reduces cellular NAD+ levels by regulating the expression of enzymes involved in NAD+ consumption and synthesis. Moreover, the infection increases the expression of sirtuin 1 (SIRT1), which inhibits EV-D68 replication in turn. Mechanistically, SIRT1 suppresses EV-D68 5′UTR-mediated translation, and the antiviral effect of SIRT1 on EV-D68 replication is enhanced by NAD+. Collectively, our findings highlight the critical role of NAD+ metabolism in EV-D68 infection and reveal the antiviral potential of SIRT1, providing valuable insights for the development of antiviral strategies.
- Open Access
- 22 December 2022
- Published by Springer Nature in Virology Journal
- Vol. 19 (1) , 1-12
ADAR1p110 promotes Enterovirus D68 replication through its deaminase domain and inhibition of PKR pathway
Background: Severe respiratory and neurological diseases caused by human enterovirus D68 (EV-D68) pose a serious threat to public health, and there are currently no effective drugs and vaccines. Adenosine deaminase acting on RNA1 (ADAR1) has diverse biological functions in various viral infections, but its role in EV-D68 infections remains undetermined. Methods: Rhabdomyosarcoma (RD) and human embryonic kidney 293 T (293 T) cells, and HeLa cells were used to evaluate the expression level of ADAR1 upon EV-D68 (Fermon strain) and human parainfluenza virus type 3 (HPIV3; NIH47885) infection, respectively. Knockdown through silencing RNA (siRNA) and overexpression of either ADAR1p110 or ADAR1p150 in cells were used to determine the function of the two proteins after viral infection. ADAR1p110 double-stranded RNA binding domains (dsRBDs) deletion mutation was generated using a seamless clone kit. The expression of ADAR1, EV-D68 VP1, and HPIV3 hemagglutinin–neuraminidase (HN) proteins was identified using western blotting. The median tissue culture infectious dose (TCID50) was applied to detect viral titers. The transcription level of EV-D68 mRNA was analyzed using reverse transcription-quantitative PCR (RT-qPCR) and the viral 5′-untranslated region (5′-UTR)-mediated translation was analyzed using a dual luciferase reporter system. Conclusion: We found that the transcription and expression of ADAR1 was inhibited upon EV-D68 infection. RNA interference of endogenous ADAR1 decreased VP1 protein expression and viral titers, while overexpression of ADAR1p110, but not ADAR1p150, facilitated viral replication. Immunofluorescence assays showed that ADAR1p110 migrated from the nucleus to the cytoplasm after EV-D68 infection. Further, ADAR1p110 lost its pro-viral ability after mutations of the active sites in the deaminase domain, and 5′-UTR sequencing of the viral genome revealed that ADAR1p110 likely plays a role in EV-D68 RNA editing. In addition, after ADAR1 knockdown, the levels of both phosphorylated double-stranded RNA dependent protein kinase (p-PKR) and phosphorylated eukaryotic initiation factor 2α (p-eIF2α) increased. Attenuated translation activity of the viral genome 5′-UTR was also observed in the dual-luciferase reporter assay. Lastly, the deletion of ADAR1p110 dsRBDs increased the level of p-PKR, which correlated with a decreased VP1 expression, indicating that the promotion of EV-D68 replication by ADAR1p110 is also related to the inhibition of PKR activation by its dsRBDs. Our study illustrates that ADAR1p110 is a novel pro-viral factor of EV-D68 replication and provides a theoretical basis for EV-D68 antiviral research.
- 22 December 2022
- Published by Springer Nature in Virology Journal
- Vol. 19 (1) , 1-12
Open AccessADAR1p110 promotes Enterovirus D68 replication through its deaminase domain and inhibition of PKR pathway
Background: Severe respiratory and neurological diseases caused by human enterovirus D68 (EV-D68) pose a serious threat to public health, and there are currently no effective drugs and vaccines. Adenosine deaminase acting on RNA1 (ADAR1) has diverse biological functions in various viral infections, but its role in EV-D68 infections remains undetermined. Methods: Rhabdomyosarcoma (RD) and human embryonic kidney 293 T (293 T) cells, and HeLa cells were used to evaluate the expression level of ADAR1 upon EV-D68 (Fermon strain) and human parainfluenza virus type 3 (HPIV3; NIH47885) infection, respectively. Knockdown through silencing RNA (siRNA) and overexpression of either ADAR1p110 or ADAR1p150 in cells were used to determine the function of the two proteins after viral infection. ADAR1p110 double-stranded RNA binding domains (dsRBDs) deletion mutation was generated using a seamless clone kit. The expression of ADAR1, EV-D68 VP1, and HPIV3 hemagglutinin–neuraminidase (HN) proteins was identified using western blotting. The median tissue culture infectious dose (TCID50) was applied to detect viral titers. The transcription level of EV-D68 mRNA was analyzed using reverse transcription-quantitative PCR (RT-qPCR) and the viral 5′-untranslated region (5′-UTR)-mediated translation was analyzed using a dual luciferase reporter system. Conclusion: We found that the transcription and expression of ADAR1 was inhibited upon EV-D68 infection. RNA interference of endogenous ADAR1 decreased VP1 protein expression and viral titers, while overexpression of ADAR1p110, but not ADAR1p150, facilitated viral replication. Immunofluorescence assays showed that ADAR1p110 migrated from the nucleus to the cytoplasm after EV-D68 infection. Further, ADAR1p110 lost its pro-viral ability after mutations of the active sites in the deaminase domain, and 5′-UTR sequencing of the viral genome revealed that ADAR1p110 likely plays a role in EV-D68 RNA editing. In addition, after ADAR1 knockdown, the levels of both phosphorylated double-stranded RNA dependent protein kinase (p-PKR) and phosphorylated eukaryotic initiation factor 2α (p-eIF2α) increased. Attenuated translation activity of the viral genome 5′-UTR was also observed in the dual-luciferase reporter assay. Lastly, the deletion of ADAR1p110 dsRBDs increased the level of p-PKR, which correlated with a decreased VP1 expression, indicating that the promotion of EV-D68 replication by ADAR1p110 is also related to the inhibition of PKR activation by its dsRBDs. Our study illustrates that ADAR1p110 is a novel pro-viral factor of EV-D68 replication and provides a theoretical basis for EV-D68 antiviral research.
- Open Access
- 15 June 2022
- Published by Springer Nature in Research Square
ADAR1p110 promotes Enterovirus D68 replication through its deaminase domain and inhibition of PKR pathway
Background Severe respiratory and neurological diseases caused byEV-D68 pose a serious threat to public health, but there are currently no effective drugs and vaccines. ADAR1 has been reported to have diverse biological functions in various viral infections, but its role in EV-D68 infection remains undetermined. Methods RD cells, 293T cells and Hela cells were used to evaluate the expression level of ADAR1 upon EV-D68 (Ferm strain) and HPIV3 (NIH47885) infection, respectively. The knockdown through siRNA and overexpression of either ADAR1p110 or ADAR1p150 in cell lines above were utilized to determine the role of the two proteins after viral infection. ADAR1p110 dsRBDs deleted mutation was generated by seamless clone kit. The expression patterns of ADAR1, EV-D68 VP1 protein and HPIV3 HN protein were identified by western blotting. TCID50 was applied to detect viral titers. The transcription level of EV-D68 mRNA was analyzed by RT-qPCR and viral 5’UTR-mediated translation was analyzed by dual luciferase reporter gene. Conclusion Here, we found that the transcription and expression of ADAR1 was inhibited upon EV-D68 infection. RNA interference of endogenous ADAR1 decreased VP1 protein expression and viral titers, while overexpression of ADAR1p110 but not ADAR1p150 facilitated virus replication. Immunofluorescence assays showed that ADAR1p110 migrated from the nucleus to the cytoplasm after EV-D68 infection. Further, ADAR1p110 lost the pro-viral ability after mutating the key sites in the deaminase domain, and 5’-UTR sequencing of the viral genome revealed that ADAR1p110 probably plays a role in EV-D68 RNA editing. In addition, after knockdown of ADAR1, both p-PKR and p-eIF2α increased. Attenuated translation activity of viral genome 5’-UTR was also shown in dual-luciferase reporter gene assay. At last, deletion of ADAR1p110 dsRBDs increased PKR phosphorylation, which incurs a lower level of VP1 expression, indicating that the promotion of EV-D68 replication by ADAR1p110 is also related to the inhibition of PKR activation by its double stranded RNA binding domains (dsRBDs). Together, our work illustrates ADAR1p110 as a novel pro-viral factor of EV-D68 replication and provides a theoretical basis for EV-D68 antiviral research.
- 15 June 2022
- Published by Springer Nature in Research Square
Open AccessADAR1p110 promotes Enterovirus D68 replication through its deaminase domain and inhibition of PKR pathway
Background Severe respiratory and neurological diseases caused byEV-D68 pose a serious threat to public health, but there are currently no effective drugs and vaccines. ADAR1 has been reported to have diverse biological functions in various viral infections, but its role in EV-D68 infection remains undetermined. Methods RD cells, 293T cells and Hela cells were used to evaluate the expression level of ADAR1 upon EV-D68 (Ferm strain) and HPIV3 (NIH47885) infection, respectively. The knockdown through siRNA and overexpression of either ADAR1p110 or ADAR1p150 in cell lines above were utilized to determine the role of the two proteins after viral infection. ADAR1p110 dsRBDs deleted mutation was generated by seamless clone kit. The expression patterns of ADAR1, EV-D68 VP1 protein and HPIV3 HN protein were identified by western blotting. TCID50 was applied to detect viral titers. The transcription level of EV-D68 mRNA was analyzed by RT-qPCR and viral 5’UTR-mediated translation was analyzed by dual luciferase reporter gene. Conclusion Here, we found that the transcription and expression of ADAR1 was inhibited upon EV-D68 infection. RNA interference of endogenous ADAR1 decreased VP1 protein expression and viral titers, while overexpression of ADAR1p110 but not ADAR1p150 facilitated virus replication. Immunofluorescence assays showed that ADAR1p110 migrated from the nucleus to the cytoplasm after EV-D68 infection. Further, ADAR1p110 lost the pro-viral ability after mutating the key sites in the deaminase domain, and 5’-UTR sequencing of the viral genome revealed that ADAR1p110 probably plays a role in EV-D68 RNA editing. In addition, after knockdown of ADAR1, both p-PKR and p-eIF2α increased. Attenuated translation activity of viral genome 5’-UTR was also shown in dual-luciferase reporter gene assay. At last, deletion of ADAR1p110 dsRBDs increased PKR phosphorylation, which incurs a lower level of VP1 expression, indicating that the promotion of EV-D68 replication by ADAR1p110 is also related to the inhibition of PKR activation by its double stranded RNA binding domains (dsRBDs). Together, our work illustrates ADAR1p110 as a novel pro-viral factor of EV-D68 replication and provides a theoretical basis for EV-D68 antiviral research.
- Open Access
- 20 May 2022
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 60 (1) , 862-878
Folic acid: a potential inhibitor against SARS-CoV-2 nucleocapsid protein
Coronavirus disease 2019 is a global pandemic. Studies suggest that folic acid has antiviral effects. Molecular docking shown that folic acid can act on SARS-CoV-2 Nucleocapsid Phosphoprotein (SARS...
- 20 May 2022
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 60 (1) , 862-878
Open AccessFolic acid: a potential inhibitor against SARS-CoV-2 nucleocapsid protein
Coronavirus disease 2019 is a global pandemic. Studies suggest that folic acid has antiviral effects. Molecular docking shown that folic acid can act on SARS-CoV-2 Nucleocapsid Phosphoprotein (SARS...
- Open Access
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1) , 1807293
Curcumin Inhibits Replication of Human Parainfluenza Virus Type 3 by Affecting Viral Inclusion Body Formation
Human Parainfluenza Virus Type 3 (HPIV3) is one of the main pathogens that cause acute lower respiratory tract infections in infants and young children. However, there are currently no effective antiviral drugs and vaccines. Herein, we found that a natural compound, curcumin, inhibits HPIV3 infection and has antiviral effects on entry and replication of the virus life cycle. Immunofluorescence and western blotting experiments revealed that curcumin disrupts F‐actin and inhibits viral inclusion body (IB) formation, thus inhibiting virus replication. Curcumin can also downregulate cellular PI4KB and interrupt its colocalization in viral IBs. This study verified the antiviral ability of curcumin on HPIV3 infection and preliminarily elucidated its influence on viral replication, providing a theoretical basis for antiviral drug development of HPIV3 and other parainfluenza viruses.
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1) , 1807293
Open AccessCurcumin Inhibits Replication of Human Parainfluenza Virus Type 3 by Affecting Viral Inclusion Body Formation
Human Parainfluenza Virus Type 3 (HPIV3) is one of the main pathogens that cause acute lower respiratory tract infections in infants and young children. However, there are currently no effective antiviral drugs and vaccines. Herein, we found that a natural compound, curcumin, inhibits HPIV3 infection and has antiviral effects on entry and replication of the virus life cycle. Immunofluorescence and western blotting experiments revealed that curcumin disrupts F‐actin and inhibits viral inclusion body (IB) formation, thus inhibiting virus replication. Curcumin can also downregulate cellular PI4KB and interrupt its colocalization in viral IBs. This study verified the antiviral ability of curcumin on HPIV3 infection and preliminarily elucidated its influence on viral replication, providing a theoretical basis for antiviral drug development of HPIV3 and other parainfluenza viruses.
- Open Access
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1)
Identification of the Functional Domain of HPIV3 Matrix Protein Interacting with Nucleocapsid Protein
Human parainfluenza virus type 3 (HPIV3) is the main pathogen that causes respiratory infections in infants, young children, and the elderly. Currently, there are no vaccines and effective anti‐infective drugs. Studying the replication and proliferation mechanism of HPIV3 is helpful for exploring the targets of anti‐HPIV3 infection. Matrix protein (M) and nucleocapsid protein (N) are two key structural proteins of HPIV3 that exert important functions in HPIV3 proliferation. Herein, we aim to clarify the functional domains of M and N interaction. HPIV3 M and N expression plasmids of pCAGGS‐HA‐M and pCAGGS‐N‐Myc/Flag, M C‐terminal truncation mutant plasmids of pCAGGSHA‐MΔC120, MΔC170, MΔC190, and MΔC210, and M C‐terminal plasmid of pCAGGS‐HA‐MC190 and C‐terminal deletion mutant plasmid of pCAGGS‐MΔN143‐182 were constructed. By using immunoprecipitation, immunofluorescence, and virus‐like particle (VLP) germination experiments, we found that N was encapsulated into M‐mediated VLP through N and M interaction. Moreover, the C‐terminus of the M played a key role in the interaction between M and N. The C‐terminus of the M encapsulated the N into the VLP. We finally determined that the 143‐182 amino acids in the M were the functional regions that encapsulated the N into the M‐mediated VLP. Our findings confirmed the interaction between M and N and for the first time clarified that the 143‐182 amino acid region in M was the functional region that interacted with N, which provides a molecular basis for exploring effective anti‐HPIV3 targets.
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1)
Open AccessIdentification of the Functional Domain of HPIV3 Matrix Protein Interacting with Nucleocapsid Protein
Human parainfluenza virus type 3 (HPIV3) is the main pathogen that causes respiratory infections in infants, young children, and the elderly. Currently, there are no vaccines and effective anti‐infective drugs. Studying the replication and proliferation mechanism of HPIV3 is helpful for exploring the targets of anti‐HPIV3 infection. Matrix protein (M) and nucleocapsid protein (N) are two key structural proteins of HPIV3 that exert important functions in HPIV3 proliferation. Herein, we aim to clarify the functional domains of M and N interaction. HPIV3 M and N expression plasmids of pCAGGS‐HA‐M and pCAGGS‐N‐Myc/Flag, M C‐terminal truncation mutant plasmids of pCAGGSHA‐MΔC120, MΔC170, MΔC190, and MΔC210, and M C‐terminal plasmid of pCAGGS‐HA‐MC190 and C‐terminal deletion mutant plasmid of pCAGGS‐MΔN143‐182 were constructed. By using immunoprecipitation, immunofluorescence, and virus‐like particle (VLP) germination experiments, we found that N was encapsulated into M‐mediated VLP through N and M interaction. Moreover, the C‐terminus of the M played a key role in the interaction between M and N. The C‐terminus of the M encapsulated the N into the VLP. We finally determined that the 143‐182 amino acids in the M were the functional regions that encapsulated the N into the M‐mediated VLP. Our findings confirmed the interaction between M and N and for the first time clarified that the 143‐182 amino acid region in M was the functional region that interacted with N, which provides a molecular basis for exploring effective anti‐HPIV3 targets.
- Open Access
- 1 February 2019
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 10, 95
Involvement of Actin-Regulating Factor Cofilin in the Inclusion Body Formation and RNA Synthesis of Human Parainfluenza Virus Type 3 via Interaction With the Nucleoprotein
Human parainfluenza virus type 3 (HPIV3) is one of the primary pathogens that causing severe respiratory tract diseases in newborns and infants. It could induce inclusion bodies (IBs) in infected cells. Comprised of viral nucleoprotein (N) and phosphoprotein (P), as well as some cellular factors, HPIV3 IBs are unique platform for efficient viral synthesis. Although several studies have demonstrated the formation of IBs, little is known about cellular proteins involved in HPIV3 IBs formation. By quantitative real-time PCR assays after cytochalasin D treatment, we found actin microfilaments of the cytoskeleton were indispensible for HPIV3 RNA synthesis. Using co-immunoprecipitation and immunofluorescence assays, an actin-modulating protein, cofilin was found to involve in the IBs formation through interaction with the N protein in N–P induced IBs complex. Viral IBs formation reduced upon RNA interference knockdown of cellular cofilin, thus viral RNA synthesis and protein expression level were also suppressed. What’s more, the inactive form of cofilin, p-cofilin was increased after HPIV3 infection, and phosphorylation of cofilin was required for interacting with N–P complex and IBs formation. We further identified that the regions in cofilin interacting with N protein lies in the C-terminus. Our findings for the first time to state that cellular cofilin involves in HPIV3 IBs and interaction with N is critical for cofilin to aid IBs formation and enhancing viral RNA synthesis.
- 1 February 2019
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 10, 95
Open AccessInvolvement of Actin-Regulating Factor Cofilin in the Inclusion Body Formation and RNA Synthesis of Human Parainfluenza Virus Type 3 via Interaction With the Nucleoprotein
Human parainfluenza virus type 3 (HPIV3) is one of the primary pathogens that causing severe respiratory tract diseases in newborns and infants. It could induce inclusion bodies (IBs) in infected cells. Comprised of viral nucleoprotein (N) and phosphoprotein (P), as well as some cellular factors, HPIV3 IBs are unique platform for efficient viral synthesis. Although several studies have demonstrated the formation of IBs, little is known about cellular proteins involved in HPIV3 IBs formation. By quantitative real-time PCR assays after cytochalasin D treatment, we found actin microfilaments of the cytoskeleton were indispensible for HPIV3 RNA synthesis. Using co-immunoprecipitation and immunofluorescence assays, an actin-modulating protein, cofilin was found to involve in the IBs formation through interaction with the N protein in N–P induced IBs complex. Viral IBs formation reduced upon RNA interference knockdown of cellular cofilin, thus viral RNA synthesis and protein expression level were also suppressed. What’s more, the inactive form of cofilin, p-cofilin was increased after HPIV3 infection, and phosphorylation of cofilin was required for interacting with N–P complex and IBs formation. We further identified that the regions in cofilin interacting with N protein lies in the C-terminus. Our findings for the first time to state that cellular cofilin involves in HPIV3 IBs and interaction with N is critical for cofilin to aid IBs formation and enhancing viral RNA synthesis.
- Open Access
- 15 November 2014
- Published by American Society for Microbiology in Journal of Virology
- Vol. 88 (22) , 13173-13188
A Leucine Residue in the C Terminus of Human Parainfluenza Virus Type 3 Matrix Protein Is Essential for Efficient Virus-Like Particle and Virion Release
Paramyxovirus particles, like other enveloped virus particles, are formed by budding from membranes of infected cells, and matrix (M) proteins are critical for this process. To identify the M protein important for this process, we have characterized the budding of the human parainfluenza virus type 3 (HPIV3) M protein. Our results showed that expression of the HPIV3 M protein alone is sufficient to initiate the release of virus-like particles (VLPs). Electron microscopy analysis confirmed that VLPs are morphologically similar to HPIV3 virions. We identified a leucine (L302) residue within the C terminus of the HPIV3 M protein that is critical for M protein-mediated VLP production by regulating the ubiquitination of the M protein. When L302 was mutated into A302, ubiquitination of M protein was defective, the release of VLPs was abolished, and the membrane binding and budding abilities of M protein were greatly weakened, but the M L302A mutant retained oligomerization activity and had a dominant negative effect on M protein-mediated VLP production. Furthermore, treatment with a proteasome inhibitor also inhibited M protein-mediated VLP production and viral budding. Finally, recombinant HPIV3 containing the M L302A mutant could not be rescued. These results suggest that L302 acts as a critical regulating signal for the ubiquitination of the HPIV3 M protein and virion release. IMPORTANCE Human parainfluenza virus type 3 (HPIV3) is an enveloped virus with a nonsegmented negative-strand RNA genome. It can cause severe respiratory tract diseases, such as bronchiolitis, pneumonia, and croup in infants and young children. However, no valid antiviral therapy or vaccine is currently available. Thus, further elucidation of its assembly and budding will be helpful in the development of novel therapeutic approaches. Here, we show that a leucine residue (L302) located at the C terminus of the HPIV3 M protein is essential for efficient production of virus-like particles (VLPs). Furthermore, we found L302 regulated M protein-mediated VLP production via regulation of M protein ubiquitination. Recombinant HPIV3 containing the M L302A mutant is growth defective. These findings provide new insight into the critical role of M protein-mediated VLP production and virion release of a residue that does not belong to L domain and may advance our understanding of HPIV3 viral assembly and budding.
- 15 November 2014
- Published by American Society for Microbiology in Journal of Virology
- Vol. 88 (22) , 13173-13188
Open AccessA Leucine Residue in the C Terminus of Human Parainfluenza Virus Type 3 Matrix Protein Is Essential for Efficient Virus-Like Particle and Virion Release
Paramyxovirus particles, like other enveloped virus particles, are formed by budding from membranes of infected cells, and matrix (M) proteins are critical for this process. To identify the M protein important for this process, we have characterized the budding of the human parainfluenza virus type 3 (HPIV3) M protein. Our results showed that expression of the HPIV3 M protein alone is sufficient to initiate the release of virus-like particles (VLPs). Electron microscopy analysis confirmed that VLPs are morphologically similar to HPIV3 virions. We identified a leucine (L302) residue within the C terminus of the HPIV3 M protein that is critical for M protein-mediated VLP production by regulating the ubiquitination of the M protein. When L302 was mutated into A302, ubiquitination of M protein was defective, the release of VLPs was abolished, and the membrane binding and budding abilities of M protein were greatly weakened, but the M L302A mutant retained oligomerization activity and had a dominant negative effect on M protein-mediated VLP production. Furthermore, treatment with a proteasome inhibitor also inhibited M protein-mediated VLP production and viral budding. Finally, recombinant HPIV3 containing the M L302A mutant could not be rescued. These results suggest that L302 acts as a critical regulating signal for the ubiquitination of the HPIV3 M protein and virion release. IMPORTANCE Human parainfluenza virus type 3 (HPIV3) is an enveloped virus with a nonsegmented negative-strand RNA genome. It can cause severe respiratory tract diseases, such as bronchiolitis, pneumonia, and croup in infants and young children. However, no valid antiviral therapy or vaccine is currently available. Thus, further elucidation of its assembly and budding will be helpful in the development of novel therapeutic approaches. Here, we show that a leucine residue (L302) located at the C terminus of the HPIV3 M protein is essential for efficient production of virus-like particles (VLPs). Furthermore, we found L302 regulated M protein-mediated VLP production via regulation of M protein ubiquitination. Recombinant HPIV3 containing the M L302A mutant is growth defective. These findings provide new insight into the critical role of M protein-mediated VLP production and virion release of a residue that does not belong to L domain and may advance our understanding of HPIV3 viral assembly and budding.